Lorvotuzumab Biosimilar (NCAM1 / CD56 Reference Antibody)
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab) ) is a humanized monoclonal antibody that binds CD56 (NCAM1) . Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine.
Product Specifications
Target
Lorvotuzumab Biosimilar (Anti-NCAM1 / CD56 Reference Antibody)
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP70880-01 20 µg
Recombinant Human T-cell receptor alpha chain C region(TRAC)
Sign In for Pricing
View Details AP70880-02 100 µg
Recombinant Human T-cell receptor alpha chain C region(TRAC)
Sign In for Pricing
View Details AP70880-03 1 mg
Recombinant Human T-cell receptor alpha chain C region(TRAC)
Sign In for Pricing
View Details 